Skip to main contentSkip to navigation
Sirius Investors

WHWK Stock: Whitehawk Therapeutics Inc Stock Price, Analysis & Insights

Get live WHWK stock price $4.22, comprehensive Whitehawk Therapeutics Inc stock analysis, charts, news, and expert forecast. Real-time WHWK stock data and investment insights.

4.22
4.98%Today
WHWKWhitehawk Therapeutics Inc • NASDAQ Global Market • Healthcare
Market Cap
208.69M
Volume
361.05K
52W High
5.50
52W Low
1.57

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.

Company Information

CEO
David J. Lennon
Sector
Healthcare
Industry
Biotechnology
Employees
40

Contact Information

Address
17383 Sunset Blvd, Suite A250
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: 0.77) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Whitehawk Therapeutics Inc shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Whitehawk Therapeutics Inc
  • Investors should consider how Whitehawk Therapeutics Inc fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

208.69M

P/E Ratio (TTM)

-1.69

Beta

0.77

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.